Citation

Campbell SH, Flint KL, Haw JS, Davis GM, Vellanki P. Clinical Diabetes 2019; 37(4): 398-400.

Copyright

(Copyright © 2019)

DOI

10.2337/CD19-0016

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

adult; human; case report; family; transgender; suicidal ideation; anxiety; suicide attempt; gender dysphoria; posttraumatic stress disorder; insulin lispro; abuse; estradiol; testosterone; clinical article; prolactin; triacylglycerol; physical examination; thyrotropin; follow up; low density lipoprotein cholesterol; glucose; hypoglycemia; body weight; hormone substitution; father; insulin dependent diabetes mellitus; high density lipoprotein cholesterol; spironolactone; diabetic ketoacidosis; hemoglobin A1c; body mass; drug dose reduction; Article; drug dose increase; young adult; glycemic control; clinical classification; named groups of persons; feminization; insulin detemir; clinical outcome; medical procedures; decreased terminal facial hair; estradiol valerate; foster parent; gender affirming hormone therapy; gender affirming therapy; mammary gland growth; sexual partner; spontaneous erection; tanner 4 breasts bilaterally; transgender woman